| Literature DB >> 26954515 |
M Broekgaarden1, R van Vught2, S Oliveira3, R C Roovers3, P M P van Bergen en Henegouwen3, R J Pieters4, T M Van Gulik1, E Breukink2, M Heger1.
Abstract
Photodynamic therapy for therapy-resistant cancers will greatly benefit from targeted delivery of tumor photosensitizing agents. In this study, a strategy for the site-specific conjugation of single domain antibodies onto liposomes containing the photosensitizer zinc phthalocyanine was developed and tested.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26954515 DOI: 10.1039/c6nr00014b
Source DB: PubMed Journal: Nanoscale ISSN: 2040-3364 Impact factor: 7.790